I guess the problem many investors may have is that there is already several companies offering the same technology to the NHS. Both Goldshield Technologies and Greenfrog Enterprises have already conducted NHS trials and claim to have NHS approval for the same base chemical.
- Forums
- ASX - By Stock
- Ann: Quarterly Update and Appendix 4C
I guess the problem many investors may have is that there is...
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ZNO (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.6¢ |
Change
0.001(4.00%) |
Mkt cap ! $9.241M |
Open | High | Low | Value | Volume |
2.6¢ | 2.6¢ | 2.6¢ | $554 | 21.32K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 334384 | 2.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 41763 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4706 | 0.090 |
2 | 61000 | 0.085 |
1 | 25000 | 0.083 |
1 | 121951 | 0.082 |
1 | 10000 | 0.080 |
Price($) | Vol. | No. |
---|---|---|
0.092 | 4500 | 1 |
0.100 | 12000 | 1 |
0.110 | 10000 | 1 |
0.115 | 10000 | 1 |
0.120 | 1200 | 1 |
Last trade - 15.10pm 15/11/2024 (20 minute delay) ? |
Featured News
ZNO (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online